24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Galmed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
08:03
The end-of-year tech layoffs are not a crisis - they mark a paradigm shift
07:29
MSC denies interest in acquiring ZIM
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
5
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
More news
Galmed
4 stories about Galmed
Israeli pharmaceutical company Galmed raises $18 million during trial of its main product
22.02.21
|
James Spiro
The Nasdaq-traded company has developed a drug to treat fatty liver
Biomed at the focus of new Israel-UAE business cooperation
25.10.20
|
CTech
New cross-business initiative is led by Tel-Aviv based consultancy firm Kamir Strategy and UAE-based PR firm Cosmopole
Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering
20.06.18
|
Dror Reich
Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014